RC 344

Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving system at Medical City Dallas

Dallas, TX

Reported pricing

Low

$0

Average

$35.2k

Median

$81

High

$7433.3k

Aggregated across all available billing methodologies for this code.

Last updated: Mar 1, 2026

Compare to other hospitals

See Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving system pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.